Cargando…

Update in Pathogenesis, Diagnosis, and Therapy of Prolactinoma

SIMPLE SUMMARY: This review updates recent advances in the pathogenesis, diagnosis, and therapy of prolactinoma. Prolactinomas, comprising 30–50% of all pituitary neuroendocrine tumors, frequently occur in females aged 20 to 50 and cause hypogonadism and infertility. In typical cases, female patient...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fukuhara, Noriaki, Nishiyama, Mitsuru, Iwasaki, Yasumasa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331865/ https://www.ncbi.nlm.nih.gov/pubmed/35892862 http://dx.doi.org/10.3390/cancers14153604

Ejemplares similares

Dopamine agonist therapy for prolactinomas: do we need to rethink the place of surgery in prolactinoma management?
por: De Sousa, Sunita M C
Publicado: (2022)

Treatment of Prolactinoma
por: Inder, Warrick J., et al.
Publicado: (2022)

An update on the pathogenesis and diagnosis of Diamond–Blackfan anemia
por: Da Costa, Lydie, et al.
Publicado: (2018)

Updates in the pathogenesis, diagnosis and management of ectopic varices
por: Helmy, Ahmed, et al.
Publicado: (2008)

An update on Acanthamoeba keratitis: diagnosis, pathogenesis and treatment
por: Lorenzo-Morales, Jacob, et al.
Publicado: (2015)

The Role of Aromatase Inhibitors in Male Prolactinoma
por: Akirov, Amit, et al.
Publicado: (2023)

Fibromyalgia: Pathogenesis, Mechanisms, Diagnosis and Treatment Options Update
por: Siracusa, Rosalba, et al.
Publicado: (2021)

Thrombotic Pathogenesis and Laboratory Diagnosis in Cancer Patients, An Update
por: Akinbo, David Bolaji, et al.
Publicado: (2023)

Molecular Pathways in Prolactinomas: Translational and Therapeutic Implications
por: Biagetti, Betina, et al.
Publicado: (2021)

Approach to the Patient With Prolactinoma
por: Auriemma, Renata S, et al.
Publicado: (2023)

Prolactinomas, Cushing's disease and acromegaly: debating the role of medical therapy for secretory pituitary adenomas
por: Biller, Beverly MK, et al.
Publicado: (2010)

Disseminated Intravascular Coagulation: An Update on Pathogenesis, Diagnosis, and Therapeutic Strategies
por: Papageorgiou, Chrysoula, et al.
Publicado: (2018)

Food allergy: an updated review on pathogenesis, diagnosis, prevention and management
por: Calvani, Mauro, et al.
Publicado: (2020)

Update on pathogenesis and diagnosis flow of normoalbuminuric diabetes with renal insufficiency
por: Deng, Le, et al.
Publicado: (2021)

Central serous chorioretinopathy: updates in the pathogenesis, diagnosis and therapeutic strategies
por: Zhang, Xinyuan, et al.
Publicado: (2023)

Updated Treatment for Acne: Targeted Therapy Based on Pathogenesis
por: Kurokawa, Ichiro, et al.
Publicado: (2021)

Resistant prolactinoma: Is it monoclonal or polyclonal?
por: Kumar, K. V. S. Hari, et al.
Publicado: (2013)

Managing Prolactinomas during Pregnancy
por: Almalki, Mussa Hussain, et al.
Publicado: (2015)

Serum Survivin Increases in Prolactinoma
por: Dellal, Fatma Dilek, et al.
Publicado: (2015)

Simultaneous Convexity Meningioma and Prolactinoma
por: Figueroa-Angel, Vladimir, et al.
Publicado: (2017)

Current Challenges in the Management of Prolactinomas
por: Maiter, Dominique
Publicado: (2015)

An interesting case of cystic prolactinomas
por: Gopal, Raju A., et al.
Publicado: (2020)

Prolactinomas: evolution after menopause
por: Mallea-Gil, Maria Susana, et al.
Publicado: (2016)

Italian Guidelines for the Management of Prolactinomas
por: Cozzi, Renato, et al.
Publicado: (2023)

Porcine enteric coronaviruses: an updated overview of the pathogenesis, prevalence, and diagnosis
por: Liu, Qiang, et al.
Publicado: (2021)

An update on pathogenesis and clinical scenario for Parkinson’s disease: diagnosis and treatment
por: Adam, Hussaini, et al.
Publicado: (2023)

Bromocriptine Therapy for the Treatment of Invasive Prolactinoma: The Single Institute Experience
por: Cho, Kyung Rae, et al.
Publicado: (2013)

Evaluation of atherosclerosis after cessation of cabergoline therapy in patients with prolactinoma
por: Doğan, Berçem Ayçiçek, et al.
Publicado: (2016)

Update on the pathogenesis of vitiligo()
por: Marchioro, Helena Zenedin, et al.
Publicado: (2022)

Pathogenesis of Mucopolysaccharidoses, an Update
por: Fecarotta, Simona, et al.
Publicado: (2020)

The Mycobiome: Cancer Pathogenesis, Diagnosis, and Therapy
por: Gamal, Ahmed, et al.
Publicado: (2022)

Giant Prolactinoma of Young Onset: A Clue to Diagnosis of MEN-1 Syndrome
por: Subasinghe, Chandrika Jayakanthi, et al.
Publicado: (2018)

Antineutrophil cytoplasmic antibody-associated vasculitis, update on molecular pathogenesis, diagnosis, and treatment
por: Arman, Farid, et al.
Publicado: (2018)

Inflammatory myopathies: update on diagnosis, pathogenesis and therapies, and COVID-19-related implications
por: Dalakas, Marinos C.
Publicado: (2020)

The Effect of Prolactinoma on Tear Film Function
por: Doğan, Cezmi, et al.
Publicado: (2022)

Experience with Dopamine Agonists in the Treatment of Prolactinomas
por: Barabash, Nadiya Ye., et al.
Publicado: (2022)

Prolactinoma: Clinical Characteristics, Management and Outcome
por: Irfan, Hira, et al.
Publicado: (2022)

Cabergoline Treatment in Invasive Giant Prolactinoma
por: Alsubaie, Sadeem, et al.
Publicado: (2014)

Treatment of Prolactinomas in Low-Income Countries
por: Kruljac, Ivan, et al.
Publicado: (2015)

DICER1 mutation and pituitary prolactinoma
por: Cotton, Ellena, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ulm2a201qan2ug3chqpaac8d90